A detailed history of Tokio Marine Asset Management CO LTD transactions in Biogen Inc. stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 4,272 shares of BIIB stock, worth $591,458. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,272
Previous 4,272 -0.0%
Holding current value
$591,458
Previous $828,000 21.14%
% of portfolio
0.02%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$189.07 - $236.8 $142,558 - $178,547
754 Added 21.43%
4,272 $828,000
Q2 2024

Jul 26, 2024

BUY
$190.52 - $236.72 $20,957 - $26,039
110 Added 3.23%
3,518 $815,000
Q1 2024

May 02, 2024

BUY
$212.02 - $267.71 $98,589 - $124,485
465 Added 15.8%
3,408 $734,000
Q2 2023

Jul 28, 2023

BUY
$275.25 - $318.06 $47,893 - $55,342
174 Added 6.28%
2,943 $838,000
Q1 2023

May 11, 2023

BUY
$256.56 - $292.34 $62,344 - $71,038
243 Added 9.62%
2,769 $769,000
Q4 2022

Jan 26, 2023

BUY
$252.44 - $306.72 $78,003 - $94,776
309 Added 13.94%
2,526 $0
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $55,486 - $76,511
285 Added 14.75%
2,217 $592,000
Q2 2022

Aug 09, 2022

BUY
$187.54 - $223.02 $34,694 - $41,258
185 Added 10.59%
1,932 $394,000
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $11,238 - $14,160
-58 Reduced 3.21%
1,747 $368,000
Q4 2021

Jan 26, 2022

BUY
$223.92 - $287.77 $59,786 - $76,834
267 Added 17.36%
1,805 $433,000
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $49,806 - $64,952
176 Added 12.92%
1,538 $435,000
Q2 2021

Aug 12, 2021

BUY
$259.0 - $414.71 $72,261 - $115,704
279 Added 25.76%
1,362 $472,000
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $338,915 - $397,058
-1,395 Reduced 56.3%
1,083 $303,000
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $16,538 - $24,894
70 Added 2.91%
2,478 $607,000
Q3 2020

Nov 09, 2020

BUY
$264.77 - $305.71 $397,155 - $458,564
1,500 Added 165.2%
2,408 $683,000
Q2 2020

Aug 07, 2020

BUY
$258.66 - $342.55 $13,708 - $18,155
53 Added 6.2%
908 $243,000
Q1 2020

May 12, 2020

BUY
$268.85 - $341.04 $45,973 - $58,317
171 Added 25.0%
855 $271,000
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $150,521 - $207,983
684 New
684 $203,000
Q1 2019

Apr 25, 2019

SELL
$216.71 - $338.96 $2.82 Million - $4.41 Million
-13,016 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$278.5 - $352.75 $10,861 - $13,757
39 Added 0.3%
13,016 $3.92 Million
Q3 2018

Oct 23, 2018

SELL
$293.51 - $383.83 $11,740 - $15,353
-40 Reduced 0.31%
12,977 $4.59 Million
Q2 2018

Jul 18, 2018

BUY
$257.52 - $306.91 $515 - $613
2 Added 0.02%
13,017 $3.78 Million
Q1 2018

May 03, 2018

BUY
$260.13 - $367.91 $1.25 Million - $1.77 Million
4,819 Added 58.8%
13,015 $3.56 Million
Q4 2017

Feb 05, 2018

SELL
$307.64 - $344.58 $139,360 - $156,094
-453 Reduced 5.24%
8,196 $2.61 Million
Q3 2017

Oct 30, 2017

SELL
$281.15 - $329.69 $198,491 - $232,761
-706 Reduced 7.55%
8,649 $2.71 Million
Q2 2017

Jan 11, 2018

SELL
N/A
-1,160 Reduced 11.03%
9,355 $2.54 Million
Q1 2017

Jan 11, 2018

SELL
N/A
-5,055 Reduced 32.47%
10,515 $2.88 Million
Q4 2016

Jan 11, 2018

SELL
N/A
-5,823 Reduced 27.22%
15,570 $4.42 Million
Q3 2016

Jan 11, 2018

SELL
N/A
-2,805 Reduced 11.59%
21,393 $6.7 Million
Q2 2016

Jan 11, 2018

SELL
N/A
-242 Reduced 0.99%
24,198 $5.85 Million
Q1 2016

Jan 11, 2018

BUY
N/A
24,440
24,440 $6.36 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $19.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.